Professor Richard Gallo awarded 19th annual Friedrich Merz Guest Professorship / high-caliber symposium held in Frankfurt (17 Jun 2009)
Changes in the Merz Group Management (02 Jul 2008)
The pharmaceutical company Merz is 100 years old (07 Mar 2008)
Professor Josef Rauschecker appointed as 18th annual Friedrich Merz Guest Professorship / Prestigious Symposium in Frankfurt (26 Feb 2008)
Merz Group experiences successful 2006/07 financial year (20 Nov 2007)
The Expansion Continues: Merz Invests an Additional Million Euro Sum in Dessau (26 Jul 2007)
Recommendation of Approval for the Merz Botulinum Neurotoxin Typ A in European Countries (20 Jul 2007)
Merz Pharmaceuticals and Tel Aviv University Become Partners in Novel Drug Technology Development for Treatment of Alzheimer's (10 Jul 2007)
Merz funded Alois Alzheimer Award 2007 bestowed upon Professor Dr. Agneta Nordberg (15 Jun 2007)
Alzheimer's medication Memantine exceeds blockbuster mark of 1 billion US dollars (15 May 2007)
"Change in Merz Group leadership: Professor Scheuble will be leaving the company (23 Apr 2007)
Frankfurt Biotechnology Innovation Center plans large expansion with Merz Pharma (01 Feb 2007)
Professor Mauricio Montal appointed as 17th Friedrich Merz visiting professor - Top-class symposium in Frankfurt (21 Nov 2006)
Merz wins patent dispute with Allergan (30 Oct 2006)
Bernhard Scheuble appointed as CEO of the MERZ Group (27 Sep 2006)
Change in Management in Global Research & Development at Merz Pharmaceuticals (24 Jul 2006)
Merz Pharmaceuticals GmbH acquires presence in United Kingdom with the takeover of Denfleet Pharma Ltd. (09 Jun 2006)
![back to top [link]](skin_img/skin_contentSiteInfo-backToTop-arrow.gif)
Last update: 24 Jun 2009, 02:45
produced by GPM mbH
URL: http://www.merz.com/press/press-releases/company
Last update: 24.06.2009, 14:45 Uhr
© 2009 Merz. All rights reserved.